UCSF Clinical Toxicology and Environmental Biomonitoring Lab

Established in 2012, the Gerona Lab is primarily focused on new psychoactive substances (NPS) analysis and surveillance, and environmental chemical biomonitoring. The laboratory pioneered the use of high-resolution mass spectrometry in suspect screening and non-targeted analysis applications to NPS analysis and endocrine disrupting chemicals biomonitoring. In 2015, the laboratory started developing methods for the analysis and monitoring of anti-tuberculosis drugs using hair samples as additional research focus.
Read more

Laboratory News

DEA TOX, our collaborative NPS surveillance with the DEA, announces a new synthetic cannabinoid discovered through our laboratory's analysis. See the announcement at DEA TOX, and read our 2020 Q4 Report
Gerona Lab in a Netflix series about synthetic drugs: Check out episode 2 of “The Business of Drugs” in Netflix. Watch the Series Trailer
Our response to COVID-19: Research Associate Andrew Reckers developed and validated a quantitative method to analyze remdesivir, its primary metabolite GS-441524, and dexamethasone. Learn more from our method

 

Million Marker, the laboratory’s start-up collaborator, launches new testing kits to measure environmental chemicals in our body. Check out new Million Marker offerings
Notable publication: The laboratory’s direct BPA method published in The Lancet Diabetes and Endocrinology. See our Publications in 2021
Interns to Research Associates- the team welcomes Ross Ellison and James Hurst-Hopf
Research Associate to Graduate Student- the team wishes Jonathan Melamed the best in his new adventures at Scripps
Learn more about the lab on our People page